Elexacaftor/Tezacaftor/Ivacaftor improves CFTR activity and pulmonary function in Cystic Fibrosis Patients carrying the N1303K Mutation
How important are different trials features when people decide whether to take part in cystic fibrosis clinical trials?
The combination elexacaftor/tezacaftor/ivacaftor (eti) alters the lipid composition of the lung cells irrespective of CFTR mutation
Understanding sleep in young adults with cystic fibrosis (CF) taking elexacaftor/tezacaftor/ivacaftor (ETI)